×
Click here if you are having issues using your co-pay card or your co-pay is higher than normal at the pharmacy.
close
  • Approved Use: Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.

Continue

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen & Novartis are not responsible for and do not endorse or control the content contained on this third-party website.

Continue
  1. Access to americanmigrainefoundation.org is not intended to provide medical advice or a referral to a particular physician;
  2. Patients should discuss with their physician their experience with the patient’s medical condition and should then determine if the physician is qualified to perform the procedure;
  3. Patients should discuss the risks and benefits of any procedure with their physician;
  4. americanmigrainefoundation.org is an independent entity, and not affiliated with, or an agent of, Amgen Inc.
  5. Amgen Inc. has not entered into any agreement with any doctor affiliated with americanmigrainefoundation.org to render any treatment or care to any patient, and has not evaluated the credentials, experience or expertise of any physician affiliated with, or referred through, americanmigrainefoundation.org.
  6. AMGEN INC. MAKES NO EXPRESS, IMPLIED OR STATUTORY WARRANTIES OR REPRESENTATIONS (INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) AMERICANMIGRAINEFOUNDATION.ORG. TO THE MAXIMUM EXTENT PERMITTED BY LAW, AMGEN INC. AND ITS AFFILIATES ARE NOT RESPONSIBLE FOR AND EXPRESSLY DISCLAIM ALL LIABILITY, INCLUDING WITHOUT LIMITATION, FOR DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, AND SPECIAL OR OTHER DAMAGES ARISING FROM OR RELATED TO THE USE OF ANY SERVICES OFFERED BY AMERICANMIGRAINEFOUNDATION.ORG. BY ACCESSING AMERICANMIGRAINEFOUNDATION.ORG, YOU AGREE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW THAT YOU WILL HOLD AMGEN INC. AND ITS AFFILIATES HARMLESS FROM ANY AND ALL CLAIMS ARISING FROM OR IN CONNECTION WITH ANY ACT OR OMISSION OF AMERICANMIGRAINEFOUNDATION.ORG.

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen Inc. is not responsible for and does not endorse or control the content contained on this third-party website.

Click “OK” to proceed or “CANCEL” to return to aimovig.com

By clicking “OK” below, you acknowledge that you have read and reviewed the information contained within the Notice of Third-Party Site at the bottom of the page.

OK CANCEL

COVID-19 information center

We are in this together

We recognize this may be a challenging and stressful time. The team behind Aimovig will continue to keep you informed about important information related to Aimovig and COVID-19. We are committed to continuing to deliver Aimovig to you.

See below for a list of COVID-19 related frequently asked questions.

  • Aimovig Product Information & Supply
    • Where should I go if I have a COVID-19 question about Aimovig?

      If you have questions about Aimovig, you can reach us via phone in the U.S. at 1-800-772-6436. If you live outside of the U.S., local contact information by country can be found here. If you have any questions about your treatment plan because of concerns about COVID-19, it is important to consult with your doctor.

    • Is there any interruption to the supply of medicine based on COVID-19?

      We continue to provide an uninterrupted clinical and commercial supply of Aimovig for patients around the world and we do not currently anticipate a shortage of Aimovig due to COVID-19.

  • Aimovig & COVID-19
    • Will taking Aimovig increase the risk of contracting coronavirus (COVID-19)?

      There are no data to inform on the incidence or severity of coronavirus (COVID-19) infection in patients receiving Aimovig.

    • Does Aimovig suppress the immune system or increase risk of infection?

      Aimovig is biologic medicine that works by targeting and blocking the calcitonin gene-related peptide receptor (CGRP-R) that has been scientifically linked to migraine. In clinical trials, there has been no evidence that Aimovig suppresses the immune system.

      If you have questions about Aimovig, you can reach us via phone at 1-800-772-6436.

    • Should I stop taking Aimovig if I have COVID-19?

      There are no data to inform on the clinical course of COVID-19 in patients receiving Aimovig. However, your doctor is in the best position to determine whether you should stop taking Aimovig based on your individual medical situation. If your doctor tells you to stop taking Aimovig, they are in the best position to discuss if it is appropriate to re-start Aimovig and how long to wait before re-starting Aimovig.

    • Where should I go to find general information about COVID-19?

      Please see COVID-19 guidance from the World Health Organization or the U.S. Centers for Disease Control and Prevention. You can also find COVID-19 information from Amgen and Novartis on each company website.

  • Getting Aimovig
    • Can I get a 90-day supply (or more) of Aimovig?

      Ask your doctor to write you a prescription for 3 months for long-term medications. Or, ask your pharmacy if a 90-day fill is available. Some plans are allowing longer fills. Of course, a 90-day supply must be approved by your insurance plan and may be available during this time as an exception.

    • Can I receive my Aimovig without going to the pharmacy?

      Many pharmacies are now offering mail order, some even do it free of charge. Please call your pharmacy to see what options are available to you. You can also check your insurer’s website or call the Members Services phone line to identify what mail order pharmacy is contracted with your insurance plan.

    • Will my copay card cover a 90-day supply of Aimovig/does my insurance cover a 90-day supply?

      Your copay card will cover a 90-day supply. Individual insurance plans and coverage can vary. Talk to your insurance provider for specific information about your prescription coverage. Note, new prescriptions may be required for a 90-day fill. Ask your pharmacist for more information.

  • Taking Aimovig
    • What can I do if alcohol wipes are unavailable that are required for injection?

      During the COVID-19 pandemic, cleaning with soap and water may be an alternative. Our 70 mg/mL Instructions for Use or the 140 mg/mL Instructions for Use provide guidance that alcohol wipes are preferred. However, if you are out of alcohol wipes, please consult with your healthcare provider.

Contact us here

1-833-AIMOVIG (1-833-246-6844)

8AM–9PM ET, Mon–Fri

+ +

Important Safety Information

Who should not use Aimovig®?
Do not use Aimovig if you are allergic to erenumab-aooe or any ingredients in

Who should not use Aimovig? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

 
–

Important Safety Information

Who should not use Aimovig®? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements. What are possible side effects of Aimovig®? Aimovig® may cause serious side effects, including:
  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation or constipation associated with symptoms such as severe or constant belly pain, vomiting, swelling of belly or bloating.
  • High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare provider if you have an increase in blood pressure.
The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation. These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Click here for the full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.
References: 1. Parsabiv® (etelcalcetide) prescribing information, Amgen. 2. Data on file, Amgen; [Summary of Clinical Efficacy; 2015]. 3. Alexander ST, et al. Mol Pharmacol. 2015;88:853-865. 4. Data on file, Amgen; [Report R20130052, 2014]. 5. Chen P, et al. CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494. 6. Sensipar® (cinacalcet) prescribing information, Amgen. 7. Ma JN, et al. J Pharmacol Exp Ther. 2011;337:275-284.